Company intelligence / Profile preview

Avulux

Miami, Florida, United Statesavulux.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

The company’s patented precision optical filter lens has demonstrated both clinical and statistical superiority over placebo in a randomized double-masked clinical trial for managing light sensitivity and pain in migraine patients. Real-world data show that up to 90% of users can resume daily activities while using the lenses to manage symptoms. The product has regulatory clearance as a Class I Medical Device in Canada and has been adopted by hundreds of eye care providers globally.

Therapeutic areas
OphthalmologyNeurology
Modalities
Device (specifically therapeutic lens)Non-pharmacological therapyNanoparticle (nano-molecular technology in lens)
Industry
Therapeutic Medical Devices
02

Partnerships

John A. Moran Eye Center at University of UtahCherry Optical Lab and other US-based optical labs for distributionCR Labs Australia for local market entry/distribution

Beyond the preview

Go deeper on Avulux.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avulux.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call